{"DataElement":{"publicId":"5040696","version":"1","preferredName":"Chronic Graft Versus Host Disease Gastrointestinal Tract Involvement NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"Information related to the NIH Consensus Response Criteria for cGVHD severity of gastrointestinal tract involvement.","longName":"5040562v1.0:5040692v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5040562","version":"1","preferredName":"Chronic Graft Versus Host Disease Gastrointestinal Tract Involvement","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation._The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff._To have a connection by participation or association or use; sharing in an activity or process.","longName":"5040560v1.0:2192548v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5040560","version":"1","preferredName":"Chronic Graft Versus Host Disease Gastrointestinal Tract","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.:The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.","longName":"C4981:C34082","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gastrointestinal Tract","conceptCode":"C34082","definition":"The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-46F7-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192548","version":"1","preferredName":"Involvement","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F4C3B9-9218-0989-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-29","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-4705-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5040692","version":"1","preferredName":"Gastrointestinal Tract NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff._A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252-266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999)._Used of the degree of something undesirable e.g. pain or weather; also, strictness._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"5040692v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Score 3","valueDescription":"Symptoms associated with significant weight loss (greater than15 percent), requires nutritional supplementation for most calorie needs OR esophageal dilation OR severe diarrhea with significant interference with daily living","ValueMeaning":{"publicId":"5040693","version":"1","preferredName":"Symptoms associated with significant weight loss (greater than15 percent), requires nutritional supplementation for most calorie needs OR esophageal dilation OR severe diarrhea with significant interference with daily living","longName":"5040693","preferredDefinition":"Symptoms associated with significant weight loss (greater than15 percent), requires nutritional supplementation for most calorie needs OR esophageal dilation OR severe diarrhea with significant interference with daily living","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23543715-B42E-8478-E050-BB89AD434EE2","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23543715-B447-8478-E050-BB89AD434EE2","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"},{"value":"Score 2","valueDescription":"Symptoms associated with mild to moderate weight loss (5-15 percent) OR moderate diarrhea without significant interference with daily living","ValueMeaning":{"publicId":"5040694","version":"1","preferredName":"Symptoms associated with mild to moderate weight loss (5-15 percent) OR moderate diarrhea without significant interference with daily living","longName":"5040694","preferredDefinition":"Symptoms associated with mild to moderate weight loss (5-15 percent) OR moderate diarrhea without significant interference with daily living","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23543715-B451-8478-E050-BB89AD434EE2","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23543715-B46A-8478-E050-BB89AD434EE2","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"},{"value":"Score 1","valueDescription":"Symptoms without significant weight loss (less than 5 percent)","ValueMeaning":{"publicId":"5040695","version":"1","preferredName":"Symptoms without significant weight loss (less than 5 percent)","longName":"5040695","preferredDefinition":"Symptoms without significant weight loss (less than 5 percent)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23543715-B474-8478-E050-BB89AD434EE2","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23543715-B48D-8478-E050-BB89AD434EE2","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"},{"value":"Score 0","valueDescription":"No symptoms","ValueMeaning":{"publicId":"3476036","version":"1","preferredName":"No symptoms","longName":"3476036","preferredDefinition":"No symptoms","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8D5E-27E8-5806-E040-BB89AD43560B","latestVersionIndicator":"Yes","beginDate":"2012-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-06-08","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"23543715-B497-8478-E050-BB89AD434EE2","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5042827","version":"1","preferredName":"Gastrointestinal Tract NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.:A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252Â¿266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999).:Severity; used of the degree of something undesirable e.g. pain or weather.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C34082:C103138:C25676:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Tract","conceptCode":"C34082","definition":"The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"NIH Consensus Response Criteria for Chronic GVHD","conceptCode":"C103138","definition":"A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252-266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23CCF37B-99E7-FBD3-E050-BB89AD432528","latestVersionIndicator":"Yes","beginDate":"2015-11-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-05","modifiedBy":"ONEDATA","dateModified":"2015-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23543715-B418-8478-E050-BB89AD434EE2","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"COOPERM","dateModified":"2020-03-17","changeDescription":"Removed special characters for MDR data migration. 3.17.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"HPST_CGHD_cgvhd_GI_NIH_score","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the NIH Consensus Res","type":"Preferred Question Text","description":"What is the NIH Consensus Response Criteria for cGVHD severity of gastrointestinal tract involvement?","url":null,"context":"NHLBI"},{"name":"Gastrointestinal (GI) tract score","type":"Alternate Question Text","description":"Gastrointestinal (GI) tract score","url":null,"context":"NHLBI"},{"name":"Gastrointestinal (GI) tract score","type":"Application Standard Question Text","description":"Gastrointestinal (GI) tract score","url":null,"context":"NHLBI"},{"name":"NIH gastrointestinal (GI) tract score","type":"Alternate Question Text","description":"NIH gastrointestinal (GI) tract score","url":null,"context":"NHLBI"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"GI Tract:","url":null,"context":"COG"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23543715-B4A2-8478-E050-BB89AD434EE2","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":".AQT added for 2100r7. 04/23/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}